Investigating phenotypic heterogeneity in aggression and understanding the molecular biological basis of aggression subtypes may lead to new prevention and treatment options. In the current study, we evaluated the taxonomy of aggression and examined specific genetic mechanisms underlying aggression subtypes in healthy males and females. Confirmatory Factor Analysis (CFA) was used to replicate a recently reported three-factor model of the Reactive Proactive Questionnaire (RPQ) in healthy adults (n=661; median age 24.0 years; 41% male). Gene-set association analysis, aggregating common genetic variants within (a combination of) three molecular pathways previously implicated in aggression, i.e. serotonergic, dopaminergic, and neuroendocrine signaling, was conducted with MAGMA software in males and females separately (total n =395) for aggression subtypes. We replicate the three-factor CFA model of the RPQ, and found males to score significantly higher on one of these factors compared to females: proactive aggression. The genetic association analysis showed a female-specific association of genetic variation in the combined gene-set with a different factor of the RPQ; reactive aggression due to internal frustration. Both the neuroendocrine and serotonergic genesets contributed significantly to this association. Our genetic findings are subtype-and sex- specific, stressing the value of efforts to reduce heterogeneity in research of aggression etiology. Importantly, subtype-and sex-differences in the underlying pathophysiology of aggression suggest that optimal treatment options will have to be tailored to the individual patient. Male and female needs of intervention might differ, stressing the need for sex-specific further research of aggression. Our work highlights opportunities for sample size maximization offered by population-based studies of aggression.
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Introduction
Aggression has been defined as any behavior directed toward the goal of causing harm or injury to others (Baron and Richardson, 1994) . From an evolutionary perspective, aggressive behaviors can be adaptive and have an important role in survival and competition for resources (Georgiev et al., 2013) . In modern societies, aggression often is maladaptive and associated with negative consequences, causing psychological and somatic burden to victims as well as to aggressive individuals themselves (Fergusson et al., 2005; Reef et al., 2010) . Aggression poses a substantial financial burden on society, for example caused by increased legal costs and work absence (WHO, 2007) . A better understanding of the subtypes and etiology of aggression is needed to facilitate prevention and to improve treatment options (Fergusson et al., 2005) . Given that about half of the variance in aggressive behaviors may be explained by genetic influences (Tuvblad and Baker, 2011; Veroude et al., 2016) , studying the molecular genetics underlying these behaviors can provide important mechanistic insights. Research into aggression etiology is, however, complicated by several factors, including considerable phenotypic as well as genetic heterogeneity and the existence of sex differences in aggressive behaviors (Baker et al., 2008; Georgiev et al., 2013) .
Subtypes of aggression
Heterogeneity in the etiology of aggression may be parsed by considering subtypes. Different classification systems have been proposed; one based on biological hypotheses is the distinction of proactive and reactive aggression (Dodge and Coie, 1987) . Proactive aggression, also referred to as instrumental aggression, is goal-oriented, organized behavior often associated with low autonomic arousal and affect. Reactive aggression on the other hand, is also known as impulsive or affective aggression, and occurs in response to provocation or a negative emotional state (Raine et al., 2006; Stanford et al., 2003) . Importantly, the subtypes have been associated with distinct behavioral, neurocognitive, and neural characteristics. For example, proactive aggression has been related to psychopathic traits and delinquent behavior (Cima and Raine, 2009; Cima et al., 2013) , while the reactive subtype of aggression has been associated with impulsivity, anxiety, and hostile interpretation bias (Brugman et al., 2015; Bubier and Drabick, 2009) . Twin studies showed slightly higher heritability estimates for proactive than reactive aggression (Baker et al., 2008; Brendgen et al., 2005; Tuvblad et al., 2009 ). The two aggression subtypes may have partially distinct genetic contributions. Serotonergic and dopaminergic neurotransmission may regulate both reactive and proactive aggression, whereas endocrine signaling seems to be more involved in the regulation of reactive aggression, e.g. through modulation of impulsivity and the stress response (Waltes et al., 2015) . Recently, a further subdivision of reactive aggression has been proposed based on an exploratory factor analysis of the Reactive Proactive Questionnaire (RPQ). This analysis was conducted in a sample of adolescents (71.6% male), who were referred to clinical services for externalizing behavior problems . Besides a proactive factor, reactive aggression was further subdivided into a subtype associated with external provocation or threat and another one associated with internal frustration. Improved fit indices for this three factor model compared to the original two-factor model were also reported based on an adult, males-only sample recruited partly in forensic psychiatric in-and outpatient clinics and partly from the general population. (Brugman et al., 2016) . The reactive subtypes differed in their associated behavioral correlates, which suggests that the three-factor model may further reduce phenotypic heterogeneity and facilitate the search for genes involved in the etiology of aggression.
Sex differences in aggression
The most convincing observation supporting the existence of sex differences in aggression is the difference in crime rate statistics between males and females. Females are vastly less likely to commit serious offenses than males, and males are more likely to display antisocial behavior than females (Stephenson et al., 2014) . Males are also overrepresented in aggression-related disorders such as conduct disorder (CD), where the gender ratio is approximately 2.5 (Hill, 2002) . Importantly, sex differences are also found in the type of aggressive behavior displayed (Collett et al., 2003) . The clear gender-specificity of aggression is thought to have evolved by sexual selection, and to reflect differences in optimal strategies in the competition for resources for males and females (Georgiev et al., 2013) . Sex differences in heritability estimates have been observed in some but not all of the aggression twin studies conducted to date, with higher heritability estimates for boys than girls, when self-report measures were assessed (Baker et al., 2008; Wang et al., 2013) . Incorporation of sex in aggression studies may be essential to identify the underlying biological mechanisms of aggressive behaviors.
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Biological systems
The biological systems most investigated in the context of aggression phenotypes (as well as related traits such as mood disturbances and impulsivity) are the monoaminergic neurotransmitter systems related to serotonin and dopamine and the neuroendocrine system. Multiple reviews to date discuss these systems in the context of aggression and list the candidate genes that have been investigated for association with aggressive behaviors (Pavlov et al., 2012; Veroude et al., 2016; Waltes et al., 2015) .
The serotonergic system is hypothesized to play a key role in aggression due to its influence on functions including social cognition, emotional regulation, and cognitive control (Lesch et al., 2012) . Both human and animal studies link genes within these systems to aggressive behavior. For example, the serotonin transporter gene (SLC6A4) is one of the most investigated candidate genes for aggression. Variation in the serotonin receptor 2B gene (5-HT2B) has been associated with violent impulsivity in a Finnish population, and 5-HT2B and 5-HT1B knockout studies in mice implicate these genes in aggression and/or impulsivity (Bevilacqua et al., 2010; Nautiyal et al., 2015) . While candidate genetic association studies have often produced equivocal results, investigations measuring levels of the serotonin metabolite 5-HIAA in cerebrospinal fluid, e.g. (Brown et al., 1979; Coccaro and Lee, 2010) , or manipulating central serotonin function through tryptophan depletion/loading, e.g. (Bjork, 2000) , have revealed a highly significant relationship between serotonin availability and aggression (Rosell and Siever, 2015) . Dopamine is relevant for understanding aggression because of its effects on reward, motivated behavior, and decision making (Costa et al., 2012) . While studies of dopamine manipulation have mostly been conducted in animals, the involvement of dopamine in aggression is also evidenced by the fact that in humans, D2-receptor antagonists have been used effectively to treat aggressive behavior (Nelson and Trainor, 2007) . Additional evidence linking the serotonergic and dopaminergic neurotransmitter systems comes from genetic association studies of the MAOA gene. This X-linked gene encodes the enzyme monoamine oxidase A, which breaks down both serotonin and dopamine, and has been robustly associated with aggression, especially in the context of stress and maltreatment (Brunner et al., 1993; Caspi et al., 2002; Byrd and Manuck, 2014) . The third system implicated in aggression is the neuroendocrine system, including both stress-related hypothalamic-pituitary-adrenal (HPA) axis signaling and sex-hormone-related hypothalamo-pituitarygonadal (HPG) axis signaling. As early life stress is known to increase risk for the development of mood and aggressionrelated disorders (Agid et al., 1999; Éthier et al., 2004; Fonagy, 2006; Heim et al., 2001) , the neuroendocrine stress response with its genetic components is a major candidate system for the development of aggressive behaviors. The relation of the HPA axis to aggression has been well established, especially through animal studies (Veenema, 2009) . Also in humans, cortisol levels have been related to aggression repeatedly (Alink et al., 2012; Loney et al., 2006; Popma et al., 2007; Shirtcliff et al., 2005; van Bokhoven et al., 2004) . The HPG axis involves signaling between hypothalamus, pituitary, and the gonadal glands, which produce estrogen and testosterone. Testosterone levels have been related to human aggression (Book et al., 2001; Brown et al., 2008; Chichinadze et al., 2010; Yu and Shi, 2009 ) and it has been hypothesized that especially the interplay between cortisol and sex steroids is important in determining aggression liability (Pavlov et al., 2012; Terburg et al., 2009) .
Extensive reviews of aggression candidate gene studies have recently been published Pavlov et al., 2012; Veroude et al., 2016; Waltes et al., 2015) . Although a moderate number of studies has been conducted, a meta-analysis of individual candidate variants did not reveal any significant associations with aggressive behavior (Vassos et al., 2014) . One reason for this may be the complex genetic background of aggression in most people. While a few monogenic aggression disorders caused by rare genetic variations with a high effect size exist (Brunner et al., 1993; Zhang-James et al., 2016) , aggression in the population has a complex and polygenic genetic background, which can be aggravated by environmental factors (Veroude et al., 2016 ).
In the current study, we assessed the genetic mechanisms underlying aggression subtypes in the general population. Firstly, we aimed to verify the existence of three aggression subtypes in adult males and females from the general population based on the RPQ. Second, we aimed to assess the association of common genetic variants in the three biological systems with most evidence for a role in aggression, i.e. the serotonergic system, the dopaminergic system, and the neuroendocrine system with the different subtypes. We aimed to maximize power for finding genetic associations by (1) parsing phenotypic heterogeneity through differentiating between subtypes, (2) by assessing males and females separately, and (3) by combining genetic variants in a gene-set analysis (Bralten et al., 2011; Bralten et al., 2013; Naaijen et al., 2017) .
Experimental procedures 2.1. Sample
The investigated sample consisted of participants of the Brain Imaging Genetics (BIG) study conducted at the Donders Institute for Brain, Cognition and Behaviour (Franke et al., 2010) . The BIG study consists of self-reported healthy adults, who participated in smaller-scale imaging studies at the institute and gave consent to be included in the BIG study. Saliva samples for genetic testing were collected, and an internet-based test-battery of questionnaires was applied. The Reactive Proactive Questionnaire (RPQ; Raine et al., 2006) was available for 661 participants (age range 18-45 years). Of those, 395 participants had genome-wide genotyping data available.
All participants were of Caucasian descent and were screened using a self-report questionnaire for the following exclusion criteria before study participation: a history of somatic disease potentially affecting the brain, current or past psychiatric or neurological disorder, medication (except hormonal contraceptives) or illicit drug use during the past 6 months, history of substance abuse, current or past alcohol dependence, pregnancy, lactation, menopause, and magnetic resonance imaging contraindications (Gerritsen et al., 2012) . All participants gave written informed consent, and the study was approved by the regional ethics committee. Table 1 Selected genes for each of the three gene-sets (serotonergic, dopaminergic, neuroendocrine).
Serotonergic gene-set (n=43 genes)  5HT1A  5HT1B  5HT1D  5HT1E  5HT4  5HT6  5HT7  ADCY1  ADCY10  ADCY2  ADCY3  ADCY4  ADCY5  ADCY6  ADCY7  ADCY8  ADCY9  DDC  GCH1  GNAS  HTR2A  HTR2B  HTR2C  HTR3A  HTR3B  HTR3C  HTR3D  HTR3E  HTR5A  IL4I1  MAOA  MAOB  PCBD  PTS  QDPR  SERT  SLC18A1  SLC18A2  SLC18A3  SMOX  SPR  TPH1  TPH2 Dopaminergic gene-set (n= 77 genes) ERβ  GNG13  HSPA14  KRT36  MR  PIK3CA  PRKACB  SMARCA4 TAK1  ADCY3  CCL2  FASLG  GNG2  HSPA1A  MAP2K1  MRAS  PIK3CB  PRKACG SMARCB1 TAT  ADCY5  CCL3  FCGR1  GNG3  HSPA1B  MAP2K2  NCOA2  PIK3CD  PRKAG1 SMARCC1 TBP  ADCY6  CCL5  FGG  GNG4  HSPA1L  MAP2K4  NCOA3  PIK3CG  PRKAG2 SMARCC2 TEBP  ADCY7  CCNC  FKBP51  GNG5  HSPA2  MAP2K7  NCOR1  PIK3R1  PRKAR1A SMARCD1 TFIIB  ADCY8  CCND1  FKBP52  GNG7  HSPA4  MAPK1  NCOR2  PIK3R2  PRKAR1B SMARCD2 TGFB1  ADCY9  CCNH  FOS  GR  HSPA5  MAPK10  NFAT5  PIK3R3  PRKAR2A SMARCD3 TGFB2  ADRB2  CD163  FOXO3A  GRB2  HSPA6  MAPK11  NFATC1  PIK3R4  PRKAR2B SMARCE1 TGFB3  AGT  CD247  G6PC  GTF2A1  HSPA8  MAPK12  NFATC2  PIK3R5  PRKCA  SMILE  TGFBR1  AKT1  CD3D  G6PC2  GTF2A2  HSPA9  MAPK13  NFATC3  PIK3R6  PRKCB  SOS1  TGFBR2  AKT2  CD3E  G6PC3  GTF2E1  ICAM1  MAPK14  NFATC4  PLAU  PRKCD  SOS2  THRAP3  AKT3  CD3G  GILZ  GTF2E2  IFNG  MAPK3  NFKB1  PLCG1  PRKCE  SRA1  TNF  ANF  CDK7  GLI1  GTF2F1  IGFBP1  MAPK8  NFKB2  PLCG2  PRKCG  SRC  TRA  ANXA1  CDK8  GLI2  GTF2F2  IKBKB  MAPK9  NFKBIA  POLR2A  PRKCH  SRC-1  TRAF2  AR  CDKN1A  GLI3  GTF2H1  IKBKE  MED10  NFKBIB  POLR2B  PRKCI  SRY  TRAF6  ARA55  CDKN1C  GNA11  GTF2H2  IKBKG  MED12  NFKBIE  POLR2C  PRKCQ  STAT1  TRB  ARA70  CEBPα  GNA12  GTF2H3  Il10  MED12L  NIK  POLR2D  PRKCZ  STAT3  TRRAP  ARID1A  CEBPβ  GNA13  GTF2H4  IL13  MED13  NOS1  POLR2E  PRKD1  STAT5A  TSG101  ARID2  CHP1  GNA14  GTF2H5  IL1B  MED13L  NOS2  POLR2F  PRKD3  STAT5B  UBC9  ATF2  CHUK  GNA15  GUCY1A2 IL1R2  MED15  NOS3  POLR2G  PRKDC  SUMO1  VCAM1  ATF4  COX2  GNAI1  GUCY1A3 IL1RA  MED16  NPR1  POLR2H  PRL  TAB1  VIPR1  ATM  CREB  GNAI2  GUCY1B3 IL2  MED17  NPR2  POLR2I  RAC1  TAF1  YWHAH  BAG1  CRH  GNAI3  GUCY2C  IL3  MED18  NR0B2  POLR2J  RAF1  TAF10  BCL2  CRHR1  GNAL  GUCY2D  IL4  MED20  NR4A1  POLR2J2 REA  TAF11  BCL2L1  CRHR2  GNAO1  GUCY2F  IL5  MED21  NRAS  POLR2J3 RELA  TAF12  BDNF  CSF2  GNAQ  H3F3A  IL6  MED23  OPN1SW POLR2K  RIP140  TAF13  BGLAP  CSN2  GNAS  H3F3B  IL8  MED24  PAI1  POLR2L  RRAS  TAF15  BRAF  CTBP1  GNAT1  HBO1  ITPR1  MED27  PBRM1  POMC  RRAS2  TAF1L  BRD7  CTBP2  GNAT2  HDAC3  ITPR2  MED30  PBX  POU2F1  RTA  TAF2  CALM1  CXCL2  GNAZ  HIST1H3C ITPR3  MED31  PCAF  POU2F2  RUNX2  TAF3  CALM2  DAX1  GNB1  HIST2H3C IVL  MED4  PCK1  PPP3CA  SELE  TAF4  CALM3  DDX5  GNB1L  HIST3H3  JAK1  MED6  PCK2  PPP3CB  SGK1  TAF4B  CALML5 DPF1  GNB2  HLTF  JAK2  MEF2A  PELP1  PPP3CC  SHARP  TAF5  CALR  DRIP150  GNB2L1  HMG-1  JAK3  MEF2B  PGC-1  PPP3R1  SHBG  TAF5L  CAMK4  DRIP205  GNB3  HNRNPD  JUN  MEF2C  PGR  PPP3R2  SHC  TAF6  CARM1  ELK1  GNB4  HRAS  JUND  MEF2D  PHF10  PRKAA1  SLPI  TAF6L Bold: Located on the X-or Y-chromosome or not captured by the genotyping array. The selected dopamine and serotonin pathway-sets overlap in 24 genes. The neuroendocrine set overlaps with the serotonin-set in 9 genes and with the dopamine-set in 19 genes.
Aggression questionnaire
The Reactive Proactive Questionnaire (RPQ) was used to assess subtypes of aggression (Raine et al., 2006) . The RPQ is a self-report questionnaire consisting of 23 items. For each item, subjects are asked to indicate, how often they have engaged in a given type of behavior. Items are rated on a three-point Likert scale ('never' =0, 'sometimes' =1, 'often' =2). Responses were summed to yield the three factors that best described the RPQ in an earlier exploratory factor analysis : 'proactive aggression', 'reactive aggression due to internal frustration', and 'reactive aggression due to external provocation'. Items relating to each subtype can be found in Supplementary Table 1 .
Factor analysis
Confirmatory factor analysis (CFA) was conducted using Mplus (version 6.11; https://www.statmodel.com/). Results were considered acceptable, when both the Comparative Fit Index (CFI) and the Tucker-Lewis Index (TLI) exceeded .90 (with values closer to 1 indicating better fit), and the Root Mean Squared Error of Approximation (RMSEA) was below .06 (with values closer to 0 indicating better fit) (Hu and Bentler, 1999; Smeets et al., 2016) .
Genotyping and imputation
Genetic analyses were carried out at the Department of Human Genetics of the Radboud University Medical Center. Saliva samples were collected using Oragene kits (DNA Genotek, Kanata, Canada), and genomic DNA was extracted as specified by the manufacturer. Genome-wide genotyping was performed on two different platforms, Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix Inc., Santa Clara, CA, USA) (n=243) and the Infinium PsychArray-24 v1.1 BeadChip (http://www.illumina.com/products/psycharray. html) (n=152). Genotype calling and quality control steps are described in the Supplementary Information. MACH software was used for haplotype phasing and minimac for the final imputation (Howie et al., 2012; Li et al., 2010) , with 1000 Genomes Phase 1.v3 reference data .
Gene-set selection and construction
Gene selection for aggression candidate gene-sets involved in neuroendocrine signaling, dopamine neurotransmission, and serotonin neurotransmission was performed using the Ingenuity Pathway Analysis (IPA) software (http://www.ingenuity.com). Ingenuity draws on the Ingenuity Knowledge Base which is based on information from published literature as well as on various other sources including gene expression and gene annotation databases. The serotonergic gene-set contained genes involved in serotonergic receptor signaling and de dopaminergic gene-set contained genes involved in dopaminergic receptor signaling. The neuroendocrine gene-set contained genes involved in corticotropin-releasing hormone, glucocorticoid, androgen, and estrogen signaling. An overview of selected genes can be found in Table 1 . All single nucleotide polymorphisms (SNPs) in or within 100 kb flanking regions of the genes (also capturing regulatory sequences) were selected for analysis.
Gene-set analyses
Genome-wide association analyses for the three subtypes of aggression were performed using Mach2qtl/Mach2dat (Li et al., 2010) , adjusting for age, age 2 , and four population components derived from multidimensional scaling analysis. For RPQ proactive aggression scores only, scores were dichotomized into high-and low-scoring (score Z 2 and score r 1, respectively), because of a highly positively skewed distribution (Supplementary Figure 1) . Separate analyses were run for males and females, and for subjects genotyped on the two different genotyping arrays. SNPs with low imputation quality (R 2 o0.6) and minor allele frequency of less than 1% were filtered out. Resulting SNP p-values for each of the traits were used to run gene-set analysis using MAGMA v1.04 (de Leeuw et al., 2015) . SNPs were mapped onto genes using 1000 Genomes Phase 1.v3 reference data followed by computation of gene p-values. Fixedeffects meta-analysis of the output of the two genotyping arrays was run using the weighted Stouffer's Z method as implemented in MAGMA. We first assessed association of all three gene-sets combined on the three aggression subtypes. The MAGMA competitive gene-set analysis was used to assess association, which will correct for confounding due to gene-size, gene density, differential sample size and the log of those values. Results of the self-contained test option in MAGMA, which tests whether a signal is present in the aggregated set of SNPs compared with a signal being present by random chance, are also reported for comparability with previously used methods in literature. This association method does not take into account genesize and gene density, or whether the association of the gene-set is greater than that of other genes. Results were considered significant if they reached the Bonferroni-corrected P-value-threshold for testing of three aggression subtypes and two sexes (P-value threshold =0.05/6 =0.0088). For significant associations observed in the competitive test, we performed post-hoc tests to localize effects amongst the three separate gene-sets and individual genes within the sets. An additional post-hoc analysis assessed association of all three gene-sets combined using the two-factor classification of reactive and proactive aggression (Supplementary Information).
Results
The general characteristics of our sample of 661 participants and the genotyped sample of n=395 are shown in Table 2 . The tree factor model of the RPQ, consisting of a proactive factor, a reactive factor due to internal frustration, and a reactive factor due to external provocation or threat, showed a good model fit in the healthy adults (RMSEA 90% CI: .041-.051, RMSEA: .046, CFI: .915, TLI: .905), Cronbach's alpha = 0.687 (proactive), 0.663 (reactive internal frustration), 0.684 (reactive external provocation). An overview of fit-measures for one-, two-, and three-factor models are provided in Supplementary Table 2. In line with earlier studies, inter-correlations between the three investigated aggression subtypes were moderate and significant in our investigated sample (.436 Z r r .574), marking them as distinguishing but correlated dimensions of aggression.
Gene-set association analysis with aggression subtypes was conducted in the 395 subjects with genotyping information available. Males scored significantly higher on proactive aggression than females in the genotyped (t(393) = 5.97, P o0.001) as well as the phenotyped cohort (t(659) = 6.59, Po0.001). A total of 483 unique autosomal genes were selected for the combined dopaminergic, serotonergic, and neuroendocrine gene-set. Twenty additional genes, either located on the X-and Y-chromosome or not captured by the array, could not be included in the analysis (Table 1) .
Association analysis of all three gene-sets combined with each of the three aggression subtypes was performed for males and females separately (Table 3 ). In females, the combined gene-set was significantly associated with frustration-based reactive aggression, but not with reactive aggression due to external provocation/threat or with proactive aggression scores. The significant association of the combined set with reactive aggression due to internal frustration as measured by competitive testing was observed for both genotyping arrays (P Affymetrix_competitive =1.397e-03 and P Infinium_competitive =2.175e-04, respectively), showing replicability of the finding. In males, the combined gene-set was not associated with any of the aggression subtypes using competitive tests. Post-hoc analysis results, comparing our main association results with associations based on the two-factor model of reactive and proactive aggression, can be found in the Supplementary Information. Self-contained test results were highly significant for proactive aggression scores in both males and females.
For the significant finding for reactive aggression due to internal frustration in females, we subsequently explored contributions of the three separate gene-sets and of individual genes within these sets. As shown in Table 4 , these post-hoc analyses showed that the neuroendocrine and the serotonergic gene-set were independently contributing to the association. Separate tests of each of the subsets of the neuroendocrine pathway (corticotropin-releasing hormone, glucocorticoid, estrogen, and androgen signaling cascades) provided evidence for contributions of each of these cascades to the association, with lowest p-values for glucocorticoid and androgen signaling (Table 4) . No single genes showed significant associations after Bonferroni correction for 40 (serotonin), 73 (dopamine) and 411 (neuroendocrine) genes tested (Supplementary Table 3 ). The gene with the strongest association in the serotonergic set was the serotonin transporter (SLC6A4, P = 0.0098), and the gene with the strongest association in the neuroendocrine set was Cyclin-Dependent Kinase-Activating Kinase Complex Subunit (CCNH, P = 0.0004).
Discussion
In the current study, we investigated genetic mechanisms underlying aggression subtypes in the healthy population. Factor analysis confirmed that three correlated but separate dimensions of aggression can be distinguished in healthy adults, using the self-report scale RPQ ('proactive aggression', 'reactive aggression due to internal frustration', and 'reactive aggression due to external provocation'). Aggregated analysis of common variants within monoaminergic and neuroendocrine systems confirmed association of these systems with reactive aggression due to internal frustration in females.
Our results confirming the existence of three distinguishable dimensions of aggression in healthy adults are in line with the previous study investigating alternative factor solutions for the RPQ in adults (Brugman et al., 2016) . These authors reported improved fit-indices in exploratory factor analysis for the three-factor model compared to the original two-factor model in a males-only sample, recruited partly in forensic psychiatric in-and outpatient clinics and partly from the general population. The first study to find the three-factor structure of the RPQ investigated a younger sample of adolescents, all from clinical samples . The current study extends these findings further by showing them to be valid in a highly educated healthy population sample. The specificity of our finding for 2.54 (1.98;0-9) a RPQ proactive aggression scores were dichotomized into high-and low-scoring (score Z 2 and score r 1, respectively), because of a highly positively skewed distribution in both males and females one of the subtypes, underscores the biological meaningfulness of the observed three-factor structure. The scores for both reactive subtypes showed a normal distribution in our general population sample; proactive aggression scores were heavily skewed towards the lower end, reflecting the fact that proactive aggression includes more severe behaviors less prevalent in the general population. Proactive aggression scores were significantly higher for males compared to females in our sample of healthy adults. In general, males and females have been shown to differ markedly, both in terms of prevalence and type of aggression displayed. Males are at increased risk of showing overt/physical aggression (Baillargeon et al., 2007; Côté, 2007; Hill et al., 2006) , while females may show slightly more indirect aggression (also termed social aggression, relational aggression) compared to males (Card et al., 2008) . As proactive aggression is often displayed in a covert manner, and reactive aggressive behavior is more overt, it has been suggested that girls show more proactive aggression and boys show more reactive aggression (Kempes et al., 2005) . However, prior studies that have investigated gender-differences in rates of proactive and reactive aggression in children do not confirm this idea. A study of the prevalence of proactive and reactive aggression in a sample of clinically referred children and adolescents did not find gender differences for either of the subtypes (Connor et al., 2003) . Studies in non-referred children did find differences, and reported higher rates of both reactive and proactive aggression in boys (Salmivalli and Nieminen, 2002; Baker et al., 2008) . It has been suggested that gender-differences may be more pronounced in non-clinical samples (Connor et al., 2003) . In our current study of healthy adults, we only find higher proactive (not reactive) aggression scores in males, suggesting that an age effect may also be at play. It has been hypothesized that proactive aggression may become more pronounced at a later age, when cognitive abilities are fully developed and aggressive behaviour may become more calculative in nature (Kempes et al., 2005) , a hypothesis that warrants further investigation in future studies.
Our identified association of candidate genetic systems with reactive aggression due to internal frustration in females was driven by variation in serotonergic and neuroendocrine signaling. This finding is in line with literature describing specific effects of serotonin, cortisol, and the sex steroids on aggressive behavior. Indeed, the reported associations of these molecules with aggression often differ as a function of sex and type of aggression studied (reviewed in Rosell and Siever, 2015) . For example, higher cortisol reactivity was reported for reactive aggression compared to proactive aggression (Lopez-Duran et al., 2008) . One influential theory hypothesizes that a high testosterone/ cortisol ratio predisposes to increased aggression, with serotonin modulating the balance between impulsive and instrumental aggression. Specifically, the high testosterone/ cortisol ratio is thought to facilitate the fight-flight response by acting on the amygdala-hypothalamus-periaqueductal gray network, while low serotonin reduces inhibitory control by the prefrontal cortex, together leading to increased impulsive, reactive aggression (Montoya et al., 2012) . It is interesting to mention that, although not significant after correcting for the number of genes tested, the gene with the strongest association in our serotonergic set was the serotonin transporter (SLC6A4). This is one of the most investigated candidate genes for aggression (Veroude et al., 2016) and has been associated with antisocial behavior in meta-analysis (Ficks and Waldman, 2014) .
Our finding for neuroendocrine and serotonergic signaling was specific to one of the two reactive aggression subtypes, i.e. the frustration-based reactive subtype. Although geneset association of reactive aggression as defined by the twofactor classification was also significant (Supplementary Information), providing evidence for the usefulness of the two-factor model in research of aggression etiology, our analysis using three subtypes shows that the association was strongly driven by frustration-based reactive aggression and not by threat-based reactive aggression, underscoring the biological meaningfulness of the three-factor structure. This highlights the value of the further reduction of phenotypic heterogeneity for the identification of underlying biological mechanisms of aggression. One of the characteristics of the frustration-based subtype is thought to be an inflexibility to changes in the environment . Our specific finding of strong association of frustration-based reactive aggression with neuroendocrine and serotonergic genes may thus arise (partly) from the function of these genes in stress modulation. However, more research is needed to assess the complex interactions and mechanisms through which the investigated systems lead to aggression-related phenotypes. In this context it will be useful to investigate the effects of early environment on the epigenome and the genetic factors moderating these effects (Provencal et al., 2015) . Additionally, imaging genetics studies will be instrumental in investigating the modulation of aggression brain circuitry by aggression risk genes (Bogdan et al., 2017; Thompson et al., 2014) .
Our findings were female-specific, a possible explanation for which lies in the idea that the signaling and interaction of the endocrine HPA and HPG axes is different between the sexes. For example, the two axes contribute to androgen production in different proportions in the different sexes (Burger, 2002; Montoya et al., 2012) . In general, males and females probably developed different aggression strategies during evolution as a result of sex-specific sex hormone signaling (Georgiev et al., 2013) . When using self-contained tests, we found a highly significant association of the gene-set with proactive aggression scores in both sexes. While no biological inferences can be made regarding the tested systems based on self-contained tests, nominally significant competitive association results for proactive aggression in males might nevertheless potentially point towards a role of the investigated systems in proactive aggression risk in males. The sex-specificity of at least some of our findings forms an important starting point into genetic differences in aggressive behavior between males and females. With most studies to date including male subjects only, the aggression phenotype in females specifically has been understudied and deserves more attention.
This study provides new information on the underlying mechanisms of aggression, thereby facilitating the search for diagnostic, preventive, and treatment options based on understanding biology. Importantly, from a clinical perspective, the sex and subtype specificity of our findings emphasizes the need for individually tailored treatment options. For example, our genetic association results suggest there is a biological aspect to sexual dimorphism. Fundamental differences in underlying pathophysiology may have important consequences for therapeutic interventions, suggesting that male and female needs for intervention might differ markedly.
Our study should be viewed in the context of specific strengths and limitations. One strength of the current study is the large sample size used to verify the factor structure of the RPQ. Moreover, the study addresses three different types of heterogeneity, tackling issues with phenotypic, sex-related, and allelic heterogeneity. By aggregating the effect of multiple genetic variants relating to the biological processes implicated in aggressive behavior, we were able to boost statistical power for finding genetic association (Naaijen et al., 2017) . Nevertheless, power of the study provided limited opportunity for an expansion of the number of variables investigated. Future studies should further investigate correlates of female reactive aggression that could serve to explain our main association results. Possible variables of interest are provided by a study by Connor and coworkers (2003) , who specifically investigated the correlates of proactive and reactive aggression in males and females separately. They showed that while a large amount of variance in male reactive aggression was mediated by hyperactive/impulsive behaviors, a large amount of explained variance in female reactive aggression was mediated by early traumatic stress (Connor et al., 2003) . X-and Y-linked genetic variation could not be taken into account in our study, and we were thus unable to include genetic variation in the wellknown MAOA gene in the analysis. Including this variation may further improve power of genetic studies, however, the assumed underlying polygenic risk model (many genetic variants, each with small effect size, are assumed to contribute to the phenotype) was sufficiently captured in the current analysis. Our study of aggression was performed in healthy individuals. In doing so, we assumed a model in which patients diagnosed with aggression disorders can be seen as the extremes in a distribution of aggressive traits. Several lines of research have already shown that this model is relevant in other psychiatric traits such as attention-deficit/hyperactivity disorder and autism spectrum disorders Middeldorp et al., 2016; Riglin et al., 2016; Robinson et al., 2016) . We selected genes based on their implication in aggression disorders, and indeed, were able to find association with aggressive traits in the general population. Showing that common genetic variants underlying aggression phenotypes are similar in typical and psychiatric populations, this offers many possibilities for future research. While recruitment of large clinical cohorts often proves challenging, large populationbased samples are much easier to investigate, offering important opportunities for sample size maximization.
We provide evidence for the existence of three correlated but separate dimensions of aggression in healthy adults, and identify variation in neuroendocrine and serotonergic signaling as a biological risk factor involved in the etiology of frustrationbased reactive aggression in females. To our knowledge, this is the first study investigating the combined effect of common genetic variants related to monoaminergic and neuroendocrine signaling on aggression subtypes. The findings stress the value of reducing phenotypic and sex-related heterogeneity in research of aggression etiology, and the opportunities offered by population-based studies of aggression. centre, and the Max Planck Institute for Psycholinguistics. The Cognomics Initiative is supported by the participating departments and centres and by external grants, that is, the Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL), the Hersenstichting Nederland, and the Netherlands Organisation for Scientific Research (NWO). None of the funding sources had a role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
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